121 related articles for article (PubMed ID: 2113532)
1. Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells.
Kashani-Sabet M; Wang W; Scanlon KJ
J Biol Chem; 1990 Jul; 265(19):11285-8. PubMed ID: 2113532
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A suppresses cisplatin-induced oncogene expression in human cancer cells.
Scanlon KJ; Wang WZ; Han H
Cancer Treat Rev; 1990 Dec; 17 Suppl A():27-35. PubMed ID: 2092869
[TBL] [Abstract][Full Text] [Related]
3. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.
Scanlon KJ; Jiao L; Funato T; Wang W; Tone T; Rossi JJ; Kashani-Sabet M
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10591-5. PubMed ID: 1660142
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of azidothymidine cytotoxicity in cisplatin-resistant human ovarian carcinoma cells.
Scanlon KJ; Funato T; Pezeshki B; Tone T; Sowers LC
Cancer Commun; 1990; 2(10):339-43. PubMed ID: 1698426
[TBL] [Abstract][Full Text] [Related]
5. The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas.
Funato T; Yoshida E; Jiao L; Tone T; Kashani-Sabet M; Scanlon KJ
Adv Enzyme Regul; 1992; 32():195-209. PubMed ID: 1496917
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid.
Lu Y; Han J; Scanlon KJ
J Biol Chem; 1988 Apr; 263(10):4891-4. PubMed ID: 3258308
[TBL] [Abstract][Full Text] [Related]
7. [Circumventing drug resistance in human tumors by antisense ribozyme].
Funato T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):336-42. PubMed ID: 8109989
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin induction of c-fos and c-myc expression and deoxyribonucleic acid synthesis in rat granulosa cells.
Delidow BC; White BA; Peluso JJ
Endocrinology; 1990 May; 126(5):2302-6. PubMed ID: 2109683
[TBL] [Abstract][Full Text] [Related]
9. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
Futscher BW; Erickson LC
Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
[TBL] [Abstract][Full Text] [Related]
10. [Detection of drug resistant-genes in cisplatin-resistant colon carcinoma cells by RT-PCR assay. II].
Funato T; Tone T; Miyachi H; Ishimori A
Rinsho Byori; 1993 Feb; 41(2):197-202. PubMed ID: 8361021
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
12. Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity.
Taverna P; Hansson J; Scanlon KJ; Hill BT
Carcinogenesis; 1994 Sep; 15(9):2053-6. PubMed ID: 7923602
[TBL] [Abstract][Full Text] [Related]
13. Influence of the proto-oncogene c-fos on cisplatin sensitivity.
Moorehead RA; Singh G
Biochem Pharmacol; 2000 Feb; 59(4):337-45. PubMed ID: 10644041
[TBL] [Abstract][Full Text] [Related]
14. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
15. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
16. Induction of c-fos mRNA in rat lymphoma Nb-2 cells.
Bajpai A; Andrews GK; Ebner KE
Biochem Biophys Res Commun; 1989 Dec; 165(3):1359-63. PubMed ID: 2514685
[TBL] [Abstract][Full Text] [Related]
17. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines.
Delmastro DA; Li J; Vaisman A; Solle M; Chaney SG
Cancer Chemother Pharmacol; 1997; 39(3):245-53. PubMed ID: 8996528
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.
Scanlon KJ; Kashani-Sabet M; Sowers LC
Cancer Commun; 1989; 1(4):269-75. PubMed ID: 2534792
[TBL] [Abstract][Full Text] [Related]
19. Sequential protooncogene expression during rat liver regeneration.
Thompson NL; Mead JE; Braun L; Goyette M; Shank PR; Fausto N
Cancer Res; 1986 Jun; 46(6):3111-7. PubMed ID: 3516391
[TBL] [Abstract][Full Text] [Related]
20. Regulation of c-fos, c-jun, jun-B, and c-myc messenger ribonucleic acids by gonadotropin and growth factors in cultured pig Leydig cell.
Hall SH; Berthelon MC; Avallet O; Saez JM
Endocrinology; 1991 Sep; 129(3):1243-9. PubMed ID: 1651842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
